UK Plan To Share Patient Data With Drug Industry Draws Ire

Law360, New York (December 5, 2011, 7:42 PM EST) -- British Prime Minister David Cameron on Monday announced a plan to make patient data from the National Health Service automatically available to private pharmaceutical companies for research, a move critics called a serious breach of privacy.

Under Cameron's plan, anonymous patient data would automatically be available for biomedical companies to use in research or to recruit patients for clinical trials. Patients can opt out if they object to their information be used, he said. The government is investing £60 million, or about $93.9 million, in creating...
To view the full article, register now.